CrushSCI.com
157.8Average days
131.5Median days
11Fastest days
477Longest days
382025 publications

Paper Review Records

All Paper Review Records

18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

104 days

Natural products targeting secondary pathological mechanisms in Duchenne muscular dystrophy: a scoping review

Authors
Maic Audo Eybi Mayer Sihombing; Min Seok Kim; Young Sook KimShow moreShow less
Affiliations
1. Korean Medicine Convergence Research Division, Korea National University of Science and Technology (UST), Daejeon, Republic of Korea; 2. Korean Medicine Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea; 3. College of Korean Medicine, Dongguk University, Gyeongju, Republic of KoreaShow moreShow less
Source PDF DOI Publisher page
59 days

Therapeutic potential of SAT-3247 in a canine model of Duchenne muscular dystrophy

Authors
Shanti S. S. Rayagiri; Johnathan K. Smid; Phil Lambert; James Jaquith; Tessa Murray; Ryan Mitchell; Frank Gleeson; Jacob G. Monast; James A. Teixeira; Yongping Yue; Matthew J. Burke; Gang Yao; Dongsheng Duan; Michael A. RudnickiShow moreShow less
Affiliations
1. Sprott Centre for Stem Cell Research, Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada; 2. Satellos Bioscience, Toronto, Canada; 3. Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, USA; 4. Department of Chemical and Biomedical Engineering, College of Engineering, University of Missouri, Columbia, USA; 5. Department of Neurology, School of Medicine, University of Missouri, Columbia, USA; 6. Department of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, USA; 7. Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, CanadaShow moreShow less
Source PDF DOI Publisher page
320 days

The RHO-GAP GRAF2 is a novel regulator of skeletal muscle mitophagy and exercise capacity

Authors
Matthew E. Combs; Qiang Zhu; Lillian Baker; Xue Bai; Graham Schwartz; Juan Liu; Jason W. Locasale; Christopher P. Mack; Joan M. TaylorShow moreShow less
Affiliations
1. Department of Pathology, University of North Carolina, Chapel Hill, USA; 2. Department of Biology, University of North Carolina, Chapel Hill, USA; 3. Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, USA; 4. McAllister Heart Institute, University of North Carolina, Chapel Hill, USA; 5. Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, USAShow moreShow less
Source PDF DOI Publisher page
94 days

Pax7a -expressing muscle precursor cells preferentially generate new fibres during larval muscle growth

Authors
Tapan G. Pipalia; James E. N. Minchin; Simon M. HughesShow moreShow less
Affiliations
1. Randall Centre for Cell and Molecular Biophysics, King’s College London, London, UK; 2. Present address: Institute for Neuroscience and Cardiovascular Research, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UKShow moreShow less
Source PDF DOI Publisher page
108 days

Nonsense readthrough by ataluren prevents physical functional decline in aged dysferlinopathy mouse model

Authors
Kyowon Seo; Jaeil Choi; Hyeyoung Kim; Jinhong ShinShow moreShow less
Affiliations
1. Department of Neurology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea; 2. Research Institute of Pusan National University Yangsan Hospital, Yangsan, KoreaShow moreShow less
Source PDF DOI Publisher page
160 days

Klhl41b orchestrates sarcomere assembly and growth to drive skeletal muscle hypertrophy in vivo

Authors
Hyewon Han; Grace R Tate; Janet Shi; Alfredo H Bongiorno; Arian Mansur; Jeffrey Widrick; Sehajpreet Gill; Esmat Karimi; Henk Granzier; Jeffrey R Moore; Vandana A GuptaShow moreShow less
Affiliations
1. Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA; 2. Department of Biological Sciences, University of Massachusetts Lowell, Lowell, USA; 3. Division of Genetics and Genomics, Boston Children’s Hospital, Boston, USA; 4. Department of Cellular and Molecular Medicine, University of Arizona, Tucson, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Skeletal Muscle take to review a manuscript?

As of 2026-11-18, CrushSCI has 18 complete review records for Skeletal Muscle. The fastest paper went from submission to acceptance in 11 days (Duchenne muscular dystrophy: from gene to gene-ius therapies, received 2026-07-06, accepted 2026-07-17); the slowest took 477 days. The average is 157.8 days and the median is 131.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.